WASHINGTON – Nearly one-third of adults diagnosed with sleep apnea are not currently receiving treatment, according to a new study from the National Sleep Foundation. “Understanding Sleep Apnea Survey ...
The best sleep trackers reveal insights into your nighttime patterns and offer actionable tips based on your health data. See our top picks from Oura, Apple and more.
Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise ...
Nyxoah announced today that it closed a series of financings that amount to up to approximately $77 million in proceeds.
Inspire Medical Systems, Inc. ( INSP) UBS Global Healthcare Conference 2025 November 10, 2025 11:45 AM EST ...
Inspire Medical Systems, Inc. is now grappling with a proposed class-action lawsuit alleging the company misled investors about the commercial readiness and demand for its critical "next generation" ...
SAN DIEGO, Nov. 7, 2025 /PRNewswire/ — Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Inspire Medical Systems, Inc. (NYSE ...
Inspire Medical Systems Inc. falsely touted its preparations for launching a new sleep apnea device, customer demand for the product, and initial successes before reporting sluggish sales, an investor ...
Today, Grant & Eisenhofer P.A. filed a class action lawsuit on behalf of City of Pontiac Reestablished General Employees' Retirement System against Inspire Medical Systems, Inc. ("Inspire Medical" or ...
Inspire Medical (NYSE: INSP) shares got a boost after hours today on third-quarter results that beat the consensus Wall ...
Medical technology company Inspire Medical Systems (NYSE:INSP) in Q3 CY2025, with sales up 10.5% year on year to $224.5 ...
Gross margin was 85.8% for the third quarter of 2025 compared to 84.1% in the third quarter of 2024. The year-over-year increase was due to higher sales volume and higher Inspire V sales mix, which ...